Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary M Horowitz

Showing results (111-120 of 260) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemiaMukta Arora, Daniel J Weisdorf, Stephen R Spellman, et al.
Cancer|January 25, 2017
Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remissionDaniel J Weisdorf, Heather R Millard, Mary M Horowitz, et al.
The New England Journal of Medicine|November 27, 2004
Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemiaMary J Laughlin, Mary Eapen, Pablo Rubinstein, et al.
British Journal of Haematology|June 6, 2003
Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell dosesOlle Ringdén, A John Barrett, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
Allogeneic hematopoietic cell transplant for prolymphocytic leukemiaMatt E Kalaycio, Manisha Kukreja, Ann E Woolfrey, et al.
Blood|April 26, 2003
Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter studyGorgun Akpek, Stephanie J Lee, Mary E Flowers, et al.
Blood|March 7, 2009
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantationOla Landgren, Ethel S Gilbert, J Douglas Rizzo, et al.
The Journal of Pediatrics|August 15, 2016
Health-Related Quality of Life among Pediatric Hematopoietic Stem Cell DonorsGalen E Switzer, Jessica Bruce, Deidre M Kiefer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 2, 2010
Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010Michael A Pulsipher, Neal S Young, Jakub Tolar, et al.
Cancer|October 7, 2015
Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902)William A Wood, Jennifer Le-Rademacher, Karen L Syrjala, et al.
Pageof 26

Showing results (111-120 of 260) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemiaMukta Arora, Daniel J Weisdorf, Stephen R Spellman, et al.
Cancer|January 25, 2017
Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remissionDaniel J Weisdorf, Heather R Millard, Mary M Horowitz, et al.
The New England Journal of Medicine|November 27, 2004
Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemiaMary J Laughlin, Mary Eapen, Pablo Rubinstein, et al.
British Journal of Haematology|June 6, 2003
Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell dosesOlle Ringdén, A John Barrett, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
Allogeneic hematopoietic cell transplant for prolymphocytic leukemiaMatt E Kalaycio, Manisha Kukreja, Ann E Woolfrey, et al.
Blood|April 26, 2003
Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter studyGorgun Akpek, Stephanie J Lee, Mary E Flowers, et al.
Blood|March 7, 2009
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantationOla Landgren, Ethel S Gilbert, J Douglas Rizzo, et al.
The Journal of Pediatrics|August 15, 2016
Health-Related Quality of Life among Pediatric Hematopoietic Stem Cell DonorsGalen E Switzer, Jessica Bruce, Deidre M Kiefer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 2, 2010
Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010Michael A Pulsipher, Neal S Young, Jakub Tolar, et al.
Cancer|October 7, 2015
Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902)William A Wood, Jennifer Le-Rademacher, Karen L Syrjala, et al.
Pageof 26